A Tribute in Glasgow
Prominent British journalists Matt Barbet and Louise Minchin are set to participate in Sir Chris Hoy’s annual Tour de 4 fundraising cycle ride in Glasgow this Sunday, September 6, 2026. The event, which aims to raise significant funds for five major UK cancer charities, serves as a poignant tribute to two broadcasting legends who lost their lives to prostate cancer: Bill Turnbull and Dermot Murnaghan.
The ride, hosted at the Sir Chris Hoy Velodrome, brings together high-profile figures, including BBC presenters Charlie Stayt and Naga Munchetty, Olympic legend Sir Steve Redgrave, and astronaut Tim Peake, all united by a commitment to raising awareness about stage four cancers. Donations collected from the event will be distributed equally among Breast Cancer Now, Cure Leukaemia, Macmillan Cancer Support, Maggie’s, and Prostate Cancer UK.
This report draws on information published by The Independent.
Honoring a Legacy of Advocacy
For Matt Barbet, the event is deeply personal. A long-time friend and cycling companion of the late Sky News anchor Dermot Murnaghan, Barbet described his participation as an honor. Murnaghan, who died on July 11, 2026, was a vocal advocate for prostate cancer awareness. Barbet noted that Murnaghan’s selfless promotion of the charity’s work will be a legacy he intends to continue.
Louise Minchin, who worked closely with former BBC Breakfast presenter Bill Turnbull, highlighted the lasting impact of his public battle with the disease. Turnbull passed away in 2022, but his decision to speak openly about his diagnosis is credited with saving numerous lives by encouraging men to prioritize their health. Minchin, who cycled alongside Murnaghan in last year’s inaugural event, emphasized that the ride provides a space for those bonded by the shared experience of losing loved ones to cancer.
The Fight for Early Detection
The event’s founder, Sir Chris Hoy, who was diagnosed with stage four prostate cancer in 2023, remains a central figure in the advocacy effort. His mission for the Tour de 4 is to demonstrate that individuals can lead fulfilling lives while managing advanced cancer, while simultaneously pushing for systemic change in healthcare.
Sir Chris has been particularly vocal about the lack of a national screening programme for prostate cancer—the only major cancer without one. He expressed optimism regarding Prostate Cancer UK’s ongoing ‘Transform’ trial, which aims to move the medical community closer to universal screening. As riders take to the course in Glasgow, the message remains clear: early detection is a critical, life-saving intervention. Participants and the public are encouraged to utilize the online risk checker available on the Prostate Cancer UK website.